Duale blames workers, medical facilities for SHA's false claims - standardmedia.co.ke
By clicking on the login button, you agree to our Terms & Conditions and the
SAN FRANCISCO, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Twist Bioscience Corporation ( TWST) investors who suffered significant losses to submit your losses now.
Twist Bioscience Corporation ( TWST) Investigation:
Twist claims it is an innovative synthetic biology and genomics company that has developed a scalable DNA synthesis platform to industrialize the engineering of biology and that the core of its platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip.
Twist’s claims came under serious question on Nov. 15, 2022, when Scorpion Capital published a scathing investigative report concluding that Twist is “[t]he latest miniaturized ‘lab-on-a-chip’ scam, just like Theranos, Berkely Lights, and other failures.”
Scorpion interviewed Twist ex-executives and manufacturing employees, customers, and competitors, and alleges in its report that: (1) Twist “is a ticking time bomb that we believe is resorting to a Worldcom-esque accounting fraud;” (2) its “[p]urported ‘Factory of the Future’ in Oregon, which Twist claims to be ramping with ~100MM of capex, appears deserted based on photographic and other evidence, leading us to believe it is a ruse for improper capitalization;” (3) “Twist’s reported gross margins of 45% are simply implausible, and we think they are actually negative;” (4) “[m]ultiple competitors internally...
By clicking on the login button, you agree to our Terms & Conditions and the